NUS NU SKIN ENTERPRISES, INC.

NUS financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1021561 Exchange: NYSE SIC: 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries) Latest filing: 10-Q filed Nov 6, 2026 Data checked: Nov 10, 2026
Showing 3 of 18 annual and 0 of 68 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Accelerated filer
Entity Type
Operating
Public Float
$390.00M (Jun 2025)
Industry (SIC)
5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
Incorporated
DE
Fiscal Year End
December (1231)
Phone
801-345-1000
EIN
870565309
Headquarters
PROVO, UT, 84601
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: NU SKIN ENTERPRISES INC (1998–2019) · NU SKIN ASIA PACIFIC INC (1996–1998) · NU SKIN ASIA INC (1996–1996)

▼ Key Metrics (TTM)

As of Sep 30, 2026
Financials
Revenue
$1.32B
Net Income
$-234.21M
Total Assets
$1.09B
Total Equity
$547.48M
Total Debt
$203.73M
Free Cash Flow
$-26.26M
Ratios
Gross Margin
67.8%
Operating Margin
-2%
Net Margin
-17.7%
Return on Equity
-42.8%
Return on Assets
-21.5%
Current Ratio
2.04x
Debt / Equity
0.37x
FCF / Assets
-2.4%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, NU SKIN ENTERPRISES, INC. recorded $1.49B of revenue, net income of $160.20M, and an operating cash inflow of $80.29M. Revenue of $1.49B sets the scale for evaluating how effectively sales translated into profit and cash during the year. Compared with $1.73B in fiscal 2024, revenue decreased 14.3%, a top-line contraction that reduced operating scale. The company reported diluted EPS of $3.18, adding a shareholder-level measure to the absolute income figures considered below. The revenue-to-assets relationship was 1.06x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

The first profit layer was $1.03B of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. The gross-profit relationship equaled 69.4% of revenue, quantifying the portion retained before operating expenses were recognized. Operating income was $65.76M, the earnings remaining from reported operations after the company’s recognized operating cost structure. The operating result equaled 4.4% of revenue, placing the absolute operating-income figure in the context of the company’s sales base. The bottom-line result was net income of $160.20M, after the operating, financing, tax, and other items recognized for the period. Net margin was 10.8%, meaning that this portion of revenue remained as net income after all recognized expenses. The earnings statement records $196.20M of pretax income, the profit base against which the reported tax provision can be assessed. The pretax margin was 13.2%, relating income before taxes directly to revenue. The company recognized $35.99M of income tax for the period, completing the transition from pretax income to net income. The effective relationship between income tax and positive pretax income was 18.3%, without assuming a statutory-rate comparison.

Liquidity and Capital Structure

The company held $1.41B of assets against $600.07M of liabilities and $805.24M of equity, revealing how the asset base was financed. The near-term balance sheet paired $547.70M of current assets with $263.73M of current liabilities at the reporting date. Current assets covered current liabilities by 2.08x, leaving a positive buffer for near-term obligations. The company held $238.63M in cash and equivalents, a narrower liquidity measure than total current assets. Measured only with cash and equivalents, coverage of current liabilities was 90.5%, excluding receivables and other current assets. The company carried $224.19M of total debt at period end, which frames its leverage and debt-service burden. The debt-to-equity relationship was 0.28x, showing how much debt the company carried for each unit of book equity. Relative to total assets, debt measured 16.0%, showing how much of the asset base was matched by borrowing. Relative to total assets, liabilities measured 42.7%, complementing the separate equity-based view of the company’s capital structure. Cash and equivalents equaled 17.0% of total assets, showing the liquid cash component within the company’s broader resource base.

Cash Flow and Earnings Quality

The company reported $80.29M of operating cash flow, a cash inflow that shows the cash generated by operations. Operating cash flow equaled 0.5x of net income, showing how strongly accounting earnings converted into cash from operations. Capital spending was $34.28M, absorbing part of the cash generated from operations before free cash flow. Relative to operating cash flow, capital expenditures measured 42.7%, connecting investment intensity with the company’s cash-generation base. After capital spending, free cash flow was $46.01M, leaving cash available for debt reduction, shareholder returns, or further investment. Relative to revenue, free cash flow equaled 3.1%, showing how much sales converted into cash after investment. Free cash flow equaled 3.3% of total assets, relating post-investment cash generation to the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for NU SKIN ENTERPRISES, INC.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $1.49B $1.73B $1.97B
Cost of Revenue $453.76M $550.23M $611.85M
Gross Profit $1.03B $1.18B $1.36B
OPERATING EXPENSES
R&D Expense $10.80M $13.00M $22.60M
SG&A Expense $432.14M $479.04M $546.86M
Other Operating Expenses (derived) $522.69M $841.40M $739.56M
Operating Income $65.76M $-151.59M $48.27M
NON-OPERATING INCOME / EXPENSE
Interest Expense - - $25.60M
Other Income/Expense $-31.78M $2.94M $3.87M
Pretax Income $196.20M $-175.05M $26.58M
Income Tax $35.99M $-28.46M $17.98M
Net Income $160.20M $-146.59M $8.60M
PER SHARE & SUPPLEMENTAL
Diluted EPS $3.18 $-2.95 $0.17
Diluted Shares 50.30M 49.66M 49.86M
EBITDA $118.02M $-81.78M $119.19M
Depreciation & Amortization $52.26M $69.81M $70.92M
Balance Sheet
ASSETS
Cash & Equivalents $238.63M $186.88M $256.06M
Short-term Investments $1.21M $11.11M $11.76M
Accounts Receivable $39.54M $50.78M $58.70M
Inventory $178.64M $190.24M $279.98M
Other Current Assets $13.11M $13.72M $17.79M
Current Assets $547.70M $538.60M $701.87M
PP&E (Net) $377.17M $379.60M $432.97M
Goodwill $83.63M $83.63M $218.17M
Intangible Assets $42.61M $74.28M $95.26M
Other Noncurrent Assets $280.19M $298.01M $247.61M
Noncurrent Assets $857.62M $930.32M $1.11B
Total Assets $1.41B $1.47B $1.81B
LIABILITIES
Accounts Payable $26.18M $34.88M $43.11M
Short-term Debt $20.00M $30.00M $25.00M
Other Current Liabilities $35.50M $35.65M $28.13M
Current Liabilities $263.73M $296.61M $328.87M
Long-term Debt $204.19M $363.61M $478.04M
Other Noncurrent Liabilities $74.51M $97.48M $106.64M
Noncurrent Liabilities $336.34M $520.85M $657.79M
Total Liabilities $600.07M $817.46M $986.66M
EQUITY
Common Stock $91.00K $91.00K $91.00K
Additional Paid-in Capital $635.99M $627.79M $621.85M
Retained Earnings $1.86B $1.71B $1.87B
Accumulated OCI $-116.11M $-124.76M $-100.01M
Total Equity $805.24M $651.46M $821.97M
Total Liabilities & Equity $1.41B $1.47B $1.81B
SUPPLEMENTAL
Total Debt $224.19M $393.61M $503.04M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $80.29M $111.74M $118.64M
Capital Expenditures $34.28M $41.58M $58.49M
Cash from Investing $170.66M $-37.96M $-134.50M
Cash from Financing $-202.40M $-133.18M $10.73M
Free Cash Flow $46.01M $70.16M $60.15M
Beginning Cash (CFS) $186.88M $256.06M $264.73M
Net Change in Cash $48.54M $-59.40M $-5.13M
Effect of FX on Cash $3.20M $-9.78M $-3.54M
Calculated Ending Cash $238.63M $186.88M $256.06M
Cash per BS $238.63M $186.88M $256.06M
Cash scope difference (CFS − BS) - - -
Cash per CFS $238.63M $186.88M $256.06M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is NU SKIN ENTERPRISES, INC.'s annual revenue?

NU SKIN ENTERPRISES, INC. reported $1.32B in revenue for trailing twelve months (ending September 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is NU SKIN ENTERPRISES, INC. profitable?

No. NU SKIN ENTERPRISES, INC. reported $-234.21M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is NU SKIN ENTERPRISES, INC.'s debt level?

NU SKIN ENTERPRISES, INC. carries $203.73M in total debt as of trailing twelve months. Total shareholders' equity stands at $547.48M.

Does NU SKIN ENTERPRISES, INC. generate free cash flow?

No. Free cash flow was $-26.26M for trailing twelve months. Operating cash flow was $15.21M.